Document
EMA's response to TB CAB letter regarding conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783)
Get document:
Download from this site |
Recommended citation: EMA's response to TB CAB letter regarding conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783). http://www.tbonline.info/media//media/uploads/documents/response_letter_to_tb_cab_06.07.12.pdf
Description
Catalogue:
None